VA

VR Adviser Portfolio holdings

AUM $2.68B
1-Year Est. Return 422.73%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+422.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.68B
AUM Growth
+$655M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$92.6M
2
+$28.9M
3
+$22.9M
4
TENX icon
Tenax Therapeutics
TENX
+$22.7M
5
ANL
Adlai Nortye
ANL
+$21.5M

Top Sells

1
+$41.6M
2
+$31.7M
3
+$28.3M
4
ERAS icon
Erasca
ERAS
+$17.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$15.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
26
Cullinan Oncology
CGEM
$830M
$19.6M 0.73%
1,379,965
HELP
27
Cybin Inc
HELP
$207M
$18.5M 0.69%
3,851,654
+11,404
SRZN icon
28
Surrozen
SRZN
$250M
$18.4M 0.69%
632,931
SEPN
29
Septerna Inc
SEPN
$1.4B
$12.2M 0.45%
506,056
-104,752
KRRO icon
30
Korro Bio
KRRO
$155M
$11.4M 0.43%
+1,009,500
ANRO icon
31
Alto Neuroscience
ANRO
$641M
$11.2M 0.42%
+500,000
ARTV
32
Artiva Biotherapeutics
ARTV
$333M
$10.4M 0.39%
1,609,569
XFOR icon
33
X4 Pharmaceuticals
XFOR
$361M
$1.37M 0.05%
+330,525
CASI
34
DELISTED
CASI Pharmaceuticals
CASI
– –
-987,259
UPB
35
Upstream Bio Inc
UPB
$384M
– –
-1,169,298
1
2